Cargando…
Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report
BACKGROUND: Various molecular-targeted therapeutic agents that inhibit cytokines and immune checkpoints are used in clinical practice. Some of these biologics that control immunity, such as anti-interleukin-17, anti-programmed cell death protein-1, and anti-cytotoxic T-lymphocyte-associated protein...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105910/ https://www.ncbi.nlm.nih.gov/pubmed/33964871 http://dx.doi.org/10.1186/s12876-021-01803-8 |